Pricing Log in Create free account

Vivos Therapeutics, Inc. (VVOS) vs Beyond Air, Inc. (XAIR)

Vivos Therapeutics, Inc. and Beyond Air, Inc. are both Medical Devices companies. Vivos Therapeutics, Inc. and Beyond Air, Inc. are of similar size ($3.6M and $3.5M). Beyond Air, Inc. grew revenue faster over the last twelve months: 60.8% against 45.2%. Vivos Therapeutics, Inc. has the higher net margin (−121.8% vs −435.7%) and the lower return on invested capital (−592.7% vs −174.9%). Across the 17 metrics below, Vivos Therapeutics, Inc. leads on 13 and Beyond Air, Inc. on 4.

Valuation

Metric VVOS XAIR Medical Devices median
P/E n/m n/m 24.94
P/S 0.08 0.20 2.66
P/B n/m 0.55 2.36
Price to free cash flow n/m n/m 28.12
EV/EBITDA n/m n/m 11.42
EV/Sales 0.38 1.14 2.76
Earnings yield (2,111.11%) (3,181.40%) (12.66%)
Free cash flow yield (1,194.75%) (1,263.80%) (7.18%)

Profitability

Metric VVOS XAIR Medical Devices median
Gross margin 61.89% 4.18% 57.76%
Operating margin (107.89%) (364.76%) (14.84%)
Net margin (121.79%) (435.71%) (14.45%)
Free cash flow margin (90.97%) (254.96%) (5.70%)
Return on equity 10,022.05% (505.67%) (10.56%)
Return on assets (101.46%) (109.80%) (17.26%)
Return on invested capital (592.70%) (174.89%) (5.22%)

Growth

Metric VVOS XAIR Medical Devices median
Revenue growth (TTM) 45.21% 60.75% 10.41%
EPS growth (last fiscal year) 6.76% 70.94% 28.17%
Revenue growth, 5-year CAGR 5.95% (0.12%) 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric VVOS XAIR Medical Devices median
Debt to equity (2.04) 7.89 0.04
Current ratio 0.21 3.31 2.67
Net debt to EBITDA (0.37) (0.19) 0.54

Dividend

Metric VVOS XAIR Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.38

Size

Metric VVOS XAIR Medical Devices median
Market cap 3.45m 3.63m 221.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack